ライフサイエンスコーパス: fluorescein angiography

1 RS) scale, optical coherence tomography, and fluorescein angiography.

2 l vessel leakage were found in the follow-up fluorescein angiography.

3 ain optical coherence tomography, and fundus fluorescein angiography.

4 and delayed or absent choroidal perfusion on fluorescein angiography.

5 with the final diagnosis made using ICGA and fluorescein angiography.

6 that are easily identified using wide-field fluorescein angiography.

7 nd the area of vessel leakage evaluated with fluorescein angiography.

8 ities that were clearly visible with FAF and fluorescein angiography.

9 vascularization (CNV) model in monkeys using fluorescein angiography.

10 chemistry, Western blot analysis, and fundus fluorescein angiography.

11 analyzed by scotopic electroretinography and fluorescein angiography.

12 me an important adjunct to biomicroscopy and fluorescein angiography.

13 and the progression of CNV was evaluated by fluorescein angiography.

14 munohistochemistry, electroretinography, and fluorescein angiography.

15 ant postsurgical CME and is complementary to fluorescein angiography.

16 sual acuity testing, fundus photography, and fluorescein angiography.

17 rculation time (MCT) were evaluated by video fluorescein angiography.

18 tion, leaking blood vessels were detected by fluorescein angiography.

19 blood flow changes were measured using video fluorescein angiography.

20 c changes were quantitated using video-based fluorescein angiography.

21 with ophthalmoscopy, fundus photography, and fluorescein angiography.

22 r detail in the fovea than seen typically in fluorescein angiography.

23 f new vessels that could not be diagnosed by fluorescein angiography.

24 ics in a manner not provided by conventional fluorescein angiography.

25 ested in a rat model and compared to that of fluorescein angiography.

26 sidered difficult or impossible to detect by fluorescein angiography.

27 al iris vessels, not distinct on intravenous fluorescein angiography.

28 were more distinct on OCTA than intravenous fluorescein angiography.

29 linical examination, fundus photography, and fluorescein angiography.

30 etinal capillary flow data in the absence of fluorescein angiography.

31 ptical coherence tomography (OCT) and fundus fluorescein angiography.

32 hy, wide-field color fundus photography, and fluorescein angiography.

33 a, with higher resolution than observed with fluorescein angiography.

34 inal blood flow velocities measured by video fluorescein angiography.

35 with resolved macular edema, and leakage on fluorescein angiography.

36 , optical coherence tomography (OCT), and/or fluorescein angiography.

37 teristics on optical coherence tomography or fluorescein angiography.

38 sions are visible on clinical examination or fluorescein angiography.

39 esions visible on ICGA but not detectable on fluorescein angiography.

40 s the late staining seen during conventional fluorescein angiography.

41 al vasculature with lower risk and cost than fluorescein angiography.

42 ain optical coherence tomography, and fundus fluorescein angiography.

43 abnormalities are typically evaluated using fluorescein angiography, a modality with known defects i

44 ng standardized color fundus photography and fluorescein angiography, a retinopathy score was generat

45 asis of en masse volumetric measurements and fluorescein angiography after laser photocoagulation.

46 Conventional fluorescein angiography also was performed.

47 They were examined by fluorescein angiography and by analysis of VEGF expressi

48 Laser-induced CNV was evaluated by fluorescein angiography and choroidal flat mounts.

49 CNV was examined by fluorescein angiography and choroidal flatmount.

50 Fundus fluorescein angiography and Doppler US were used to eval

51 In one RP patient, fluorescein angiography and fundus photography documente

52 graded scar and GA on fundus photography and fluorescein angiography and graded SHRM on time-domain a

53 n paramacular burns per eye) was assessed by fluorescein angiography and histologic evaluation.

54 sequelae of these events were examined using fluorescein angiography and histologic, enzyme, and immu

55 The lesions were evaluated by fluorescein angiography and histopathology.

56 aluation, which included fundus photography, fluorescein angiography and ICGA.

57 Baseline fluorescein angiography and indocyanine green angiograph

58 tion in the left eye, which was confirmed by fluorescein angiography and indocyanine green angiograph

59 Visual acuity, color images, and fluorescein angiography and indocyanine green angiograph

60 mice (aged 16 to 52 weeks) were subjected to fluorescein angiography and optical coherence tomography

61 al required that study eyes have evidence on fluorescein angiography and optical coherence tomography

62 Retinal fluorescein angiography and optical coherence tomography

63 Retinal photography, fluorescein angiography and postmortem histologic evalua

64 without diabetic macular edema and underwent fluorescein angiography and SD-OCT for diabetic retinopa

65 r more at 6 months, the change in leakage on fluorescein angiography and the change in foveal thickne

66 zation and/or peripheral avascular retina on fluorescein angiography and were treated with laser.

67 of the retina, a layer poorly visualized by fluorescein angiography and, to a lesser extent, in the

68 tinal neovascularization was evaluated using fluorescein-angiography and counting preretinal vascular

69 traretinal cysts on SD OCT or dye leakage on fluorescein angiography) and responded to treatment with

70 Retinal blood flow was measured using video fluorescein angiography, and blood glucose levels were m

71 Leakage was assessed by fluorescein angiography, and CNV lesion size was quantif

72 Ocular examination, visual field, fluorescein angiography, and electrophysiology testing w

73 Fundus photography, fluorescein angiography, and electroretinography were us

74 thalmic examination with fundus photography, fluorescein angiography, and electroretinography.

75 d electron microscopy, immunohistochemistry, fluorescein angiography, and examination of wholemounts

76 cs, such as early onset, cuticular drusen on fluorescein angiography, and family history of AMD.

77 gnostic tests (optical coherence tomography, fluorescein angiography, and fundus photography) and the

78 Fundus examination, fluorescein angiography, and histologic evaluation confi

79 omoses were evaluated by fundus photography, fluorescein angiography, and histologic examination.

80 gnosed with RAP based on fundus examination, fluorescein angiography, and indocyanine green angiograp

81 color photographs, fundus autofluorescence, fluorescein angiography, and indocyanine-green angiograp

82 were evaluated by color fundus photography, fluorescein angiography, and light and electron microsco

83 y, fundus photography, indocyanine green and fluorescein angiography, and magnetic resonance imaging)

84 rrected visual acuity, fundus biomicroscopy, fluorescein angiography, and OCT.

85 inical examination, fundus autofluorescence, fluorescein angiography, and optical coherence tomograph

86 nical examination, color fundus photography, fluorescein angiography, and optical coherence tomograph

87 anibizumab, bevacizumab, fundus photographs, fluorescein angiography, and optical coherence tomograph

88 a-ocular pressure, results of fundoscopy and fluorescein angiography, and outcomes two months after t

89 isions on the need to perform or not perform fluorescein angiography, and regarding treatment or retr

90 tures, refractive error, fundus examination, fluorescein angiography, and SD OCT findings at onset of

91 , infrared imaging, fundus autofluorescence, fluorescein angiography, and spectral domain-optical coh

92 free photographs, near-infrared reflectance, fluorescein angiography, and spectral-domain optical coh

93 inical examination, fundus autofluorescence, fluorescein angiography, and spectral-domain optical coh

94 on the choroidal circulation as assessed by fluorescein angiography, and there was no evidence of re

95 by (1) the presence of hyperfluorescence on fluorescein angiography; and (2) at least one other char

96 HP), optical coherence tomography (OCT), and fluorescein angiography are tools that may be used to de

97 r pigment (MP), OCT, blue light reflectance, fluorescein angiography, as well as fundus photography,

98 Fluorescein angiography assessed retinal and choroidal v

99 omes were evaluated among eyes with gradable fluorescein angiography at baseline (n = 973) and at 1 y

100 Live fundus imaging and fluorescein angiography at P17 were compared to immunofl

101 This information in combination with ICG and fluorescein angiography can help to optimize direct lase

102 tudy, ERG responses were obtained along with fluorescein angiography, CBCs, and melphalan plasma conc

103 ection rate, or optical coherence tomography/fluorescein angiography changes).

104 ment of retinal detachment was assessed with fluorescein angiography, clinical examination, or both.

105 ocular coherence tomography (OCT), and with fluorescein angiography confirmation.

106 Fluorescein angiography confirmed the sea fan neovascula

107 Fluorescein angiography demonstrates arterial wall hyper

108 ificantly larger CNV with greater leakage on fluorescein angiography developed in mutant mice.

109 Fluorescein angiography disclosed early retinal hypofluo

110 Fluorescein angiography does not image the radial peripa

111 Color fundus photography, fluorescein angiography, electroretinography, and visual

112 ers, including signs of ocular inflammation, fluorescein angiography evidence of retinal vasculitis o

113 examination plus simulated 30- or 60-degree fluorescein angiography (FA) (obtained by physically nar

114 the MRI measurements, fundus photography and fluorescein angiography (FA) also were performed on the

115 l study, 15 eyes with DR were evaluated with fluorescein angiography (FA) and color fundus photograph

116 Concurrent fluorescein angiography (FA) and indocyanine green angio

117 autofluorescence (FAF), dynamic simultaneous fluorescein angiography (FA) and indocyanine green angio

118 V detection compared to the gold standard of fluorescein angiography (FA) and OCT was determined for

119 clinical examination, as well as findings on fluorescein angiography (FA) and OCT.

120 this study using two images from each fundus fluorescein angiography (FA) and pvOCT, the measured ave

121 , and optical coherence tomography (OCT) and fluorescein angiography (FA) examinations in 12 months.

122 Follow-up fundus and fluorescein angiography (FA) examinations were conducted

123 We compare images from PV-OCT and fluorescein angiography (FA) for normal individuals and

124 e authors also compared their method against fluorescein angiography (FA) for one subject.

125 of patients who underwent same-day OCTA and fluorescein angiography (FA) for suspected CNV was evalu

126 Ultra-widefield fluorescein angiography (FA) images and spectral-domain

127 SD-OCT and fluorescein angiography (FA) images of 93 eyes of 93 pat

128 Baseline fluorescein angiography (FA) images of all CATT study ey

129 Color fundus photography and fluorescein angiography (FA) images were used to create

130 evaluated digital color fundus photographs, fluorescein angiography (FA) images, and optical coheren

131 when analyzed by age, race, fluence setting, fluorescein angiography (FA) leakage type, corticosteroi

132 Detecting CNV using fluorescein angiography (FA) may be challenging owing to

133 Fluorescein angiography (FA) may become necessary to eva

134 Fluorescein angiography (FA) results assessed by masked,

135 All image frames of a fluorescein angiography (FA) sequence are first aligned

136 Fluorescein angiography (FA) showed nonspecific retinal

137 rescence area and intensity over time during fluorescein angiography (FA) using a continuous scale an

138 Digital fundus photographs and fluorescein angiography (FA) using the RetCam (Clarity M

139 Fluorescein angiography (FA) was performed at 14 days, a

140 Fluorescein angiography (FA) was performed at day 5, 7,

141 Digital retinal imaging and fluorescein angiography (FA) were performed at an averag

142 ry, vein or uncertain) assessed by IR and/or fluorescein angiography (FA) were referenced as ground t

143 examination including structural OCT, OCT-A, fluorescein angiography (FA), and indocyanine green angi

144 atients underwent SS OCT angiography (OCTA), fluorescein angiography (FA), and indocyanine green angi

145 pectral-domain optical coherence tomography, fluorescein angiography (FA), and indocyanine green angi

146 Fundus photography, OCT, fluorescein angiography (FA), and OCT angiography were p

147 ollow-up morphology on digital color images, fluorescein angiography (FA), and optical coherence tomo

148 weeks and included color fundus photography, fluorescein angiography (FA), and optical coherence tomo

149 w-up morphology in color fundus photographs, fluorescein angiography (FA), and optical coherence tomo

150 visual acuity (BCVA), fundus biomicroscopy, fluorescein angiography (FA), and SDOCT.

151 a comprehensive ophthalmologic examination, fluorescein angiography (FA), and spectral-domain optica

152 We performed following examinations: fluorescein angiography (FA), B-scan ultrasound, spectra

153 Optical coherence tomography (OCT), fluorescein angiography (FA), color fundus photography (

154 CNV development were evaluated at day 14 by fluorescein angiography (FA), confocal volumetric analys

155 ding visual acuity (VA), fundus photography, fluorescein angiography (FA), fundus autofluorescence (F

156 photographs, fundus autofluorescence (FAF), fluorescein angiography (FA), indocyanine green angiogra

157 Imaging features obtained using fluorescein angiography (FA), indocyanine green angiogra

158 Fundus photography, fluorescein angiography (FA), indocyanine green angiogra

159 ence of fluid on OCT, presence of leakage on fluorescein angiography (FA), mean change in lesion size

160 raphy, fundus photography, autofluorescence, fluorescein angiography (FA), optical coherence tomograp

161 photography, fundus autofluorescence (FAF), fluorescein angiography (FA), spectral-domain optical co

162 A), Amsler grid testing, fundus photography, fluorescein angiography (FA), spectral-domain optical co

163 d sizes and locations that were confirmed by fluorescein angiography (FA).

164 art, optical coherence tomography (OCT), and fluorescein angiography (FA).

165 fundus examination, fundus photography, and fluorescein angiography (FA).

166 opy, optical coherence tomography (OCT), and fluorescein angiography (FA).

167 ence tomography (SD-OCT) and late leakage on fluorescein angiography (FA).

168 ed by optical coherence tomography (OCT) and fluorescein angiography (FA).

169 art, optical coherence tomography (OCT), and fluorescein angiography (FA).

170 d with commercially available 70-kHz OCT and fluorescein angiography (FA).

171 giography, fundus autofluorescence (FAF) and fluorescein-angiography (FA).

172 ging modalities (ultrasound of the arteries; fluorescein angiography, FA; MRI; and positron emission

173 Fluorescein angiography failed to demonstrate flow dynam

174 Traditionally, fundus fluorescein angiography (FFA) has been considered the re

175 entation of the FAZ using images from fundus fluorescein angiography (FFA) was applied to 26 transit-

176 undus autofluorescence (FAF) imaging, fundus fluorescein angiography (FFA), and optical coherence tom

177 raphy (ERG), fundus photography (FP), fundus fluorescein angiography (FFA), and optical coherence tom

178 In selected patients, Goldmann perimetry, fluorescein angiography, full-field electroretinography

179 hniques, including color fundus photography, fluorescein angiography, fundus autofluorescence (FAF),

180 imethod imaging comprised color photography, fluorescein angiography, fundus autofluorescence, and hi

181 Fluorescein angiography, fundus autofluorescence, and op

182 r each patient, including color photography, fluorescein angiography, fundus autofluorescence, and op

183 Clinical examination, fluorescein angiography, fundus photography, and spectra

184 Fluorescein angiography, funduscopic examination, and AD

185 Fluorescein angiography had the highest accuracy (97%, 3

186 Fluorescein angiography has shown potentially serious an

187 Fundus examination, fluorescein angiography, histology, and immunostaining w

188 CNV was evaluated by fluorescein angiography, histology, and quantitative con

189 on in vldlr(-/-) mice was examined by fundus fluorescein angiography, histology, double-staining of F

190 in all patients and were hyperfluorescent on fluorescein angiography, hypofluorescent on ICG angiogra

191 Consecutive ultra-widefield fluorescein angiography images were collected from patie

192 Ultra-widefield fluorescein angiography images were obtained in 63 eyes

193 Fluorescein angiography imaging was performed using a To

194 d perfusion and leakage at the optic disc on fluorescein angiography immediately after AION and sever

195 NV was associated with exudative features on fluorescein angiography in 82% of cases (64/78), and on

196 concerned refining its role as an adjunct to fluorescein angiography in detecting and guiding the tre

197 Patients exhibiting neovascular signs on fluorescein angiography in either eye were excluded.

198 s was used to perform ultra-widefield fundus fluorescein angiography in infants undergoing an examina

199 e has advantages as an alternative to RetCam fluorescein angiography in infants undergoing an examina

200 g tool for performing ultra-widefield fundus fluorescein angiography in infants.

201 ocated spontaneous CNV invisible to standard fluorescein angiography in mice before retinal invasion.

202 sensitivity of time domain OCT, relative to fluorescein angiography, in detecting new-onset neovascu

203 nificantly reduced LPC/DHA transport in vivo Fluorescein angiography indicated normal blood-retinal b

204 free imaging, blue autofluorescence imaging, fluorescein angiography, indocyanine green angiography,

205 Ophthalmic CT, fluorescein angiography, indocyanine green angiography,

206 ral ancillary tests such as ultrasonography, fluorescein angiography, indocyanine green angiography,

207 h various combinations of color photography, fluorescein angiography, indocyanine green angiography,

208 omplete ophthalmologic examination including fluorescein angiography, indocyanine green angiography,

209 d reflectance scanning laser ophthalmoscopy, fluorescein angiography, indocyanine green angiography,

210 (SD OCT), fundus autofluorescence (FAF), and fluorescein angiography/indocyanine green (ICG) angiogra

211 Fluorescein angiography is important in assessing vascul

212 Although fluorescein angiography is the criterion standard for ev

213 Intravenous fluorescein angiography (IVFA) does not show macular hyp

214 rapeutic technologies, including intravenous fluorescein angiography, laser photocoagulation, optical

215 lowing injection; both retinal thickness and fluorescein angiography leakage decreased in a dose-depe

216 Fluorescein angiography leakage was associated with a gr

217 Pretreatment ocular characteristics on fluorescein angiography (lesion type, area of neovascula

218 oroid were evaluated by electroretinography, fluorescein angiography, light microscopy, and three-dim

219 led fundus examinations, fundus photography, fluorescein angiography, macular perimetry using a scann

220 provider was $282.80, with 4 imaging tests (fluorescein angiography, magnetic resonance imaging, che

221 coherence tomography, presence of leakage on fluorescein angiography, mean change in lesion size, and

222 Among 467 eyes with fluorescein angiography, mean total lesion area was 12.9

223 digital color imaging, red-free photography, fluorescein angiography, near-infrared reflectance, and

224 l color imaging, spectral-domain OCT images, fluorescein angiography, OCT angiography images, and en

225 Fluorescein angiography of animals injected with fluores

226 tral-domain optical coherence tomography and fluorescein angiography of inner foveal structural abnor

227 thalmic examinations included visual acuity, fluorescein angiography, optical coherence tomography, a

228 ts, developed in both eyes of all animals on fluorescein angiography over the course of the study.

229 nce of cataract (P = .05), foveal leakage on fluorescein angiography (P = .04), and increased central

230 Intravenous fluorescein angiography performed in 1 eye depicted the

231 Ultra-widefield fluorescein angiography provides an insight into the rel

232 Retinal blood flow, using digitized video fluorescein angiography recordings, was quantitated afte

233 andard 7-field stereo fundus photography and fluorescein angiography, respectively.

234 Fluorescein angiography revealed early hyperfluorescence

235 Fluorescein angiography revealed early hypofluorescence

236 e large choroidal vessels and optic atrophy; fluorescein angiography revealed gradual restoration of

237 Fluorescein angiography revealed no choroidal neovascula

238 Fluorescein angiography revealed normal vascular patency

239 Fluorescein angiography revealed progressive neovascular

240 bvious on FA than on SD OCT, suggesting that fluorescein angiography should be performed when new-ons

241 Fluorescein angiography showed a late hyperfluorescence

242 Fluorescein angiography showed filling defects in retina

243 Fluorescein angiography showed staining during the late

244 Fluorescein angiography showed that the entire retina in

245 Fluorescein angiography, spectral domain optical coheren

246 previous time points and anatomic results on fluorescein angiography, spectral-domain ocular coherenc

247 olor photographs, near-infrared reflectance, fluorescein angiography, spectral-domain optical coheren

248 ation and proliferation were monitored using fluorescein angiography, spectral-domain optical coheren

249 ging findings, including fundus photography, fluorescein angiography, spectral-domain optical coheren

250 gathering included fundus color photographs, fluorescein angiography, spectral-domain optical coheren

251 prospective AMD DOC Study demonstrated that fluorescein angiography still remains the best method to

252 ased on standard stereoscopic viewing of the fluorescein angiography study.

253 Fluorescein angiography suggests that vascular perfusion

254 uate retinal capillary blood flow instead of fluorescein angiography, the reflectance pattern of bloo

255 Fluorescein angiography thresholds (FAVL-ED50) were also

256 esting including OCT, electrophysiology, and fluorescein angiography to differentiate optic nerve fro

257 erwent intraoperative ultra-widefield fundus fluorescein angiography using the modified Heidelberg Sp

258 inical study to determine if ultra-widefield fluorescein angiography (UWFA), spectral-domain optical

259 Ultra-wide-field fluorescein angiography (UWFA), which captures up to 200

260 ic responses were analyzed using video-based fluorescein angiography (VFA) methodology.

261 Fluorescein angiography was also performed.

262 sion that co-localized with the CNVM seen on fluorescein angiography was detected in all eyes by Fd-O

263 Follow-up fluorescein angiography was done on other animals until

264 Fluorescein angiography was performed in 17 of 43 diabet

265 On day 14, fluorescein angiography was performed to detect choroida

266 re death some animals were anesthetized, and fluorescein angiography was performed.

267 of peripheral avascular areas on intravenous fluorescein angiography was possible in 2 probands with

268 Ultra-widefield fundus fluorescein angiography was successfully performed in al

269 giogram (FA) or red-free (RF) fundus images; fluorescein angiography was used in this study because i

270 autofluorescence, and indocyanine green and fluorescein angiography, was available in most cases.

271 ence tomography (SD-OCT) and nonperfusion on fluorescein angiography, we observed that retinal capill

272 Optical coherence tomography (OCT) and fluorescein angiography were also obtained at some visit

273 with type of choroidal neovascularization on fluorescein angiography were not confirmed.

274 Clinical examination and fluorescein angiography were performed at 1 hour in all

275 phy, optical coherence tomography and fundus fluorescein angiography were performed where indicated.

276 sualized completely around the nerve head by fluorescein angiography, whereas the network was readily